Menu

BeyondSPX has rebranded as EveryTicker. We now operate at everyticker.com, reflecting our coverage across nearly all U.S. tickers. BeyondSPX has rebranded as EveryTicker.

NCS Multistage Holdings, Inc. (NCSM)

$55.31
-20.69 (-27.22%)
Get curated updates for this stock by email. We filter for the most important fundamentals-focused developments and send only the key news to your inbox.

Data provided by IEX. Delayed 15 minutes.

Company Profile

Price Chart

Loading chart...

At a glance

NCS Multistage has engineered a capital-light business model generating 70%+ free cash flow conversion and 20% EBITDA growth on 13% revenue growth, demonstrating remarkable operational leverage in a stagnating oilfield services environment where larger peers are struggling with flat to declining performance.

The company's strategic pivot toward higher-margin international markets and tracer diagnostics acquisitions is bearing fruit, with the North Sea customer base expanding from 2 to 7 customers since 2022 and the ResMetrics deal adding $5.2M in revenue and $1.5M in pre-tax income in just five months, diversifying revenue away from volatile North American onshore activity.

Trading at 7.4x free cash flow and 7.9x EBITDA with a net cash position of $29.1M, NCSM's valuation fails to reflect its superior margins (12.9% net margin vs. HAL's 5.8%) and returns (11%+ after-tax ROIC), suggesting the market misprices its capital efficiency and defensive niche positioning.